5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer

SM Alzahrani, HA Al Doghaither… - Oncology …, 2023 - spandidos-publications.com
Although 5-fluorouracil (5-FU)-based chemotherapy is the major treatment for colorectal
cancer, it has disadvantages such as systemic toxicity, lack of effectiveness and selectivity …

Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: from prediction to druggability

GC Eptaminitaki, D Stellas, B Bonavida… - Drug Resistance Updates, 2022 - Elsevier
The acquisition of cancer cell resistance to conventional chemotherapeutics is considered
the major driver of treatment failure and disease recurrence in most solid and hematological …

Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer

CR Patra, R Bhattacharya, D Mukhopadhyay… - Advanced drug delivery …, 2010 - Elsevier
The targeted delivery of a drug should result in enhanced therapeutic efficacy with low to
minimal side effects. This is a widely accepted concept, but limited in application due to lack …

Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine)

AM Bergman, HM Pinedo, GJ Peters - Drug Resistance Updates, 2002 - Elsevier
The inherent or induced resistance of tumors to cytostatic agents is a major clinical problem.
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …

Cancer combination therapies with artemisinin-type drugs

T Efferth - Biochemical pharmacology, 2017 - Elsevier
Artemisia annua L. is a Chinese medicinal plant, which is used throughout Asia and Africa
as tea or press juice to treat malaria. The bioactivity of its chemical constituent, artemisinin is …

Mismatch repair deficiency associated with overexpression of the MSH3 gene

G Marra, I Iaccarino, T Lettieri… - Proceedings of the …, 1998 - National Acad Sciences
We tested the ability of recombinant hMutSα (hMSH2/hMSH6) and hMutSβ (hMSH2/hMSH3)
heterodimers to complement the mismatch repair defect of HEC59, a human cancer cell line …

10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells

SA Krupenko, NV Oleinik - 2002 - AACR
Our studies showed that an abundant folate enzyme, 10-
formyltetrahydrofolatedehydrogenase (FDH), is strongly down-regulated in several types of …

Nucleoside transport and its significance for anticancer drug resistance

JR Mackey, SA Baldwin, JD Young, CE Cass - Drug Resistance Updates, 1998 - Elsevier
This article discusses the role of nucleoside transport processes in the cytotoxicity of
clinically important anticancer nucleosides. This article summarizes recent advances in the …

Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas

KS Bishnupuri, Q Luo, N Murmu, CW Houchen… - Gastroenterology, 2006 - Elsevier
Background & Aims: Reg IV, a secreted protein and member of the Reg multigene family, is
up-regulated in malignancies of the human gastrointestinal tract, including colorectal …

Resistance to 5-fluorouracil

RM Mader, M Müller, GG Steger - General Pharmacology: The Vascular …, 1998 - Elsevier
Primary and secondary resistance to the widely used antimetabolite 5-fluorouracil (5-FU) are
common phenomena in cancer chemotherapy. Because 5-FU still remains the agent of …